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The work carried in the research tenure has been compiled in the form of a thesis 
entitled ‘‘Synthesis and anticancer potential of combretastatin 
sulfonamide/sulfonate, quinazolinonederivatives and green synthesis of 
spirooxindole, phyrazolo-pyrimidine derivatives”. The main aim of this work is the 
design and synthesis of new conjugates of biologically active moieties combretastatin 
sulfonamide/sulfonate, quinazolinonederivatives, spirooxindole, phyrazolo-pyrimidine 
derivatives and their evaluation of cytotoxic activity as well as catalyst free green 
synthesis of spirooxindole, phyrazolo-pyrimidine derivatives.Further objective was to 
study the mechanism of action of these new active conjugates with particular focus on 
the inhibition of tubulin polymerization and the thesis has been divided into four 
chapters. 
 CHAPTER I: This chapter provides a general introduction about chemotherapeutic 
agents, particularly tubulin polymerization inhibitors such as colchicine, 
combretastatin, phenstatin, aryl oxindoles and benzene sulfonamides. 
 CHAPTER II: This chapter describes the synthesis, in-vitro and in-vivoevaluation of 
novel (Z)-3,4,5-trimethoxystyryl benzenesulfonamide/sulfonate derivatives as 
highly potent tubulin polymerization inhibitors.The potent conjugates from this 
class were further investigated fortubulinpolymerization, microtubule network 
perturbation and bioavailability studies. 
 CHAPTER III(SECTION-A):  This chapter illustrates design, synthesis and biological 
evaluation of quinazolinone-urea as potent antiproliferative agents. Further, these 
compounds have been evaluated for their cytotoxicity, inhibition of tubulin 
polymerization and apoptosis. 
 CHAPTER III (SECTION-B):  This chapter illustrates synthesis and biological 
evaluation of quinazolinone- arylpropenonesderivatives as potential anticancer 





 CHAPTER IV (SECTION-A): This section deals with the green synthesis and 
biological evaluation of new spirooxindoleconjugates as potent anticancer agents. 
Further, these compounds have been evaluated for their antimitotic activity. 
 CHAPTER IV (SECTION-B):This sectiondescribes the green synthesis and biological 
evaluation ofphyrazolo-pyrimidine congeners, mostly focused on the synthesis by 




 Cancer, characterized by uncontrolled growth or spread of abnormal cells, poses 
a significant challenge with high rates of diagnosis and mortality. In the treatment of 
cancer, chemotherapy plays a very important role in solid tumors and is used as an 
adjuvant to initial therapy by surgical or radio therapeutic procedures. Chemotherapy 
becomes critical to effective treatment because only systemic therapy can attack micro 
metastases. The chemotherapeutic agents target the fast dividing abnormal cells and can 
be categorized into functional sub groups: alkylating agents, antimetabolites, 
antibiotics, and antimitotics such as microtubule targeting agents. 
 Microtubules are protein biopolymers formed through polymerization of 
heterodimers of α- and β-tubulin. Tubulin polymerization is reversible, and the dynamic 
assembly and disassembly of microtubules are involved in a number of cell functions, 
including cell division, migration, and shape change. Many natural and synthetic 
compounds are reported to target the tubulin−microtubule system.Antimitotic agents 
derived from natural or synthetic products generally exert their effect as microtubule 
stabilizers or polymerizing agents, like taxol paclitaxel (Ia) and docetaxal (Ib), which 
block the microtubule disassembly. They bind at the -tubulin site in the microtubules 
and are used in the treatment of carcinomas, like lung, breast, ovarian and bladder. In 
contrast, microtubule destabilizers such as colchicine, vinca alkaloids, combretastatin 
A-4 and E7010 (V) bind at the -tubulin site in microtubules and cause the 
depolymerization of microtubules. Many of such agents manifest different limitations 






Combretastatin A-4 (IVa), is another excellent tubulin polymerization inhibitor 
that binds to the colchicine binding site of the tubulin and demonstrates cytotoxicity 
against a broad spectrum of human cancer cell lines including MDR cancer cells. 
However, the in vivo efficiency of CA-4 is limited due to its poor pharmacokinetics 
resulting from its high lipophilicity and low water solubility. The structural 
modifications on CA-4 has led to the development of a number of new CA-4 
derivatives that exhibit potent tubulin polymerization inhibitors such as  combretastatin 
A-4 phosphate (IVb - CA4P, Figure 1A) and CA-1 disodium phosphate (CA1P- Oxi 
4503)  as prodrugs.Similarly, amino substituted combretastatinderivative(IVc- AVE-
8063) and serine prodrug of combretastatin amine (IVd- Ombrabulin) have been 
developed. These prodrugs of CA-4 are in advanced stages of clinical studies. 
 













Synthesis, in-vitro and in-vivo Evaluation of (Z)-3,4,5-Trimethoxystyryl 
Benzenesulfonamide/sulfonate Derivatives as Highly Potent Tubulin 
Polymerization Inhibitors 
Combretastatin A-4 (CA-4) exhibits potent cytotoxicity with a broad spectrum of 
antitumor activity. CA-4 and related derivatives are microtubule inhibitors which target 
the colchicine binding site and exhibit low toxicity profiles.  Despite its potent 
cytotoxic and antitubulin activities, CA-4 failed to exhibit potent antitumor efficacy in 
animal models due to its limited water solubility (poor biosolubility). Because of its 
interesting antitumor activity and simplicity of structure, a number of CA-4 analogues 
(IVa-d) have been synthesized with modifications to ring A, ring B, and the bridge. In 
addition, the SAR studies of CA-4 analogs have shown that, both hydroxy and amino 
substituents contribute to improve anti-mitotic activity and provide the opportunity to 
structurally modify this scaffold. Particularly, the changing positions of amino group on 
combretastatins exhibits vary cytotoxicity and anti tubulin activity. The sulfonamide 
moiety is easy to install as well as it generally imparts stability and crystallinity to the 
attached pharmacophore.The beneficial influence of sulfonamide substituents on the 
anticancer potential of designed compounds have been established earlier. The 
antitubulin agents such as E7010 (V),E7070 (VI, indisulam) and the biarylsulfonamide 
(VII) constitute a few illustrative examples that are pertinent to the present work. Thus, 
it is clear from the back ground presented above, that the pharmacophores 
representedby combretastatin and sulfonamide offer excellent possibilities for 
hybridization towards the design of improved tubulin polymerization inhibitors. 
Keeping this in mind, we linked the amino and hydroxyl substituted combretastatin 






Figure 2. Chemical structure of microtubule targeting agents: colchicines (1) CA-4 (2a), CA-
4P (2b), AVE8063 (2c), AVE8062 (2d) and synthetic benzensulfonamide derivatives. 
Designed molecules 
Chemistry 
 Compounds 6a-j,7a-i and 9a-k were prepared by coupling of properly 
substituted (Z)-(3,4,5-trimethoxystyryl)anilines (2c, 21 and 22) with various 
commercially available substituted benzenesulfonylchlorides (23a-k) in a 1:4 (v/v) 
mixture of pyridine in anhydrous dichloromethane13 and (Z)-3-styrylphenyl 
benzenesulfonates (8a-i) prepared by the reaction of combretastatin (2a) with the 
similar benzenesulfonyl chlorides by using  dichloromethane as a solvent in the 
presence of triethylamine with outstanding yields. The intermediate compounds 2a, 2c, 
21 and 22 were obtained by the reduction and deprotection of their respective nitro, 




forming Wittig reaction between the suitable benzaldehydes (13-16) with 3,4,5-
trimethoxybenzyl triphenylphosphonium bromide (12) in presence of sodium hydride 
in anhydrous dichloromethane, afforded a mixture (1:1, v/v) of nitro Z-stilbenes (17-
20) and E-stilbenes as depicted in Scheme 1 and these isomers have been separated by 
column chromatography. The compounds (10a-m and 11a-f) have been achieved by the 
formation of amide bond between the stilbene-acrylic acids (27a-f and 31a-c) with a 
variety of substituted benzene sulfonamides (28a-f and 32a-c) by using EDCI/DMAP. 
Wherein, the intermediates were prepared in good yield by the Claisen–Schmidt 





Scheme 1.Reagents and conditions: (a) NaH, dry CH2Cl2, 0 °C to rt, 12 h; (b) Zn, HCO2NH4, 
MeOH, rt, 4 h;  (c) TBAF,THF 0 °C, 2 h (d) Pyridine, 0-5 °C, 4 h; (e)  TEA, CH2Cl2, 0-5 °C, 4 h. 
Scheme 2 & 3.Reagents and conditions:(a)  AC2O, NaOH, 140 °C; (b) EDCI, DMAP, TEA, 
CH2Cl2. 
Biological studies 
 The synthesized derivatives (Z)-N-(3-
styrylphenyl)benzenesulfonamides/sulfonates (6a-j, 7a-i, 8a-i, 9a-k, 10a-m and 11a-f) 
have been evaluated for their cytotoxicity against a panel of sixty human tumor cell 
lines of National cancer institute  (NCI). Over sixty compounds, eleven compounds 
were evaluated in the secondary screening at five dose concentrations with 10-fold 
dilutions which displayed remarkable antiproliferative efficacy on most of the NCI cell 
lines. Mostly B-ring linked sulphonamides (6a-j, 7a-i, 8a-iand 9a-k) exhibited 
remarkable antiproliferative activity. Specifically, the compound 7a and 9a possess 
broad spectrum of cytotoxicity within nanomolar range against most of cell lines with 
GI50 values below 0.03 µM, wherein, relatively twenty five cell lines showed GI50 
values less than 0.05 µM. 
The SAR studies have been examined for these diverse combrestatin 
sulfonamide analogs. In particular, the aryl sulphanamide has been attached on B-ring 
and cis- double bond. Mostly B-ring linked sulphonamides (6a-j, 7a-i, 8a-i and 9a-k) 
exhibited remarkable antiproliferative activity as compared to the double bond linked 






Figure.3Most active compounds cytotoxicity values 
 
Figure.4 Structure–activity relationship (SAR) and in vivo human cervical cancer HeLa 
xenograft model.Figure A, C and E represent nude mice after tumor induction. Figure D and F 
represent the mice after the treatment with 7a and 9a for 60 days respectively. Similarly, the 
figure B, represent the mice to which neither 7a nor 9a was given (vehicle control) during the 
same period. 
Summary 
 In summary, we have presented data that supports the potential for two 
molecules 7a and 9a with methoxy group at para position of C-ring of the 
trimethoxystyrylbenzenesulfonamide/sulfonates scaffold as novel anticancer agents. All 




sulfonate analogues exert promising antiproliferative by effectively inhibiting the 
tubulin polymerization and disrupt the microtubule dynamics in cancer cells. 
Compounds 7a and 9a also exhibited promising efficacy in HeLatumorxenograft model 
and have shown an excellent therapeutic window and we believe that these molecules 
have significant potential for clinical development as new anticancer agents. 
Chem. Med. Chem.2017, 9, 678-700. 
 
Design, Synthesis andBiological Evaluation of Quinazolinone-Urea 
Derivatives as Potential Anticancer Agents 
In continuation of our interest in the design and development of new anticancer 
agents, by simple heteroaromatic organic compounds like quinazolinone that possess 
promising cytotoxic activity. Recently we reported that quinazolinone-
chalconesderivatives and Urea derivatives that were exhibitedpromising cytotoxic 
activity. Quinazolinones are important due to their wide range of biological activities 
such as antitumor, anti-angiogenesis and anti vascular activity. Some of the 
quinazolinonepharmacophores like HMJ-38 (VIII)is reported as the most potent 2-
phenyl-4-quinozolinone derivatives (IXtoXII) in inhibiting the tubulin polymerization 
and showed significant cytotoxicity against several human tumor cell lines.  
 








By collecting the above facts, we have synthesized a series of quinazolinone 
urea derivatives (6a-j, 7a-j, 8a-e, and 9a-e) and tested for their cytotoxic activity 
against various human cancer cell lines. Compounds 7a and7c exhibited significant 
antiproliferative activity against all most of the cell lines, with IC50 value of < 1 µM. 
All synthesized compounds (6a-j, 7a-j, 8a-e, and 9a-e)displayed cytotoxicity against 
A549 (non-small cell lung cancer), HeLa (cervical carcinoma), MCF-7 (breast cancer) 
and B16 (colon carcinoma) with IC50 values ranging from 0.65-5.60µM. Cell cycle 
assay revealed that these compounds arrested the G2/M phase of the cell 
cycle.Flowcytometric analysis revealed that these conjugates arrested the cell cycle at 
the G2/M phase. In addition, compounds 7aand 7cexhibited inhibitory effect on the 
tubulin assembly with an IC50 value of 0.65µM and 0.85µM respectively. Moreover, 
Hoechst staining, and activation of caspase-3 suggested that these conjugates (7aand7c) 
induce cell death by apoptosis. Molecular docking studies demonstrate these conjugates 
effectively bind with the colchine binding site of the tubulin. Overall, this investigation 
describes the synthesis of quinazolinone-ureaderivatives as potential anticancer agents 
with apoptosis inducing ability by targeting tubulin. 
 
Chemistry. 
 The cyclizedquinazoliinoneurea (7a-j and 9a-e) derivatives were prepared by 




quinazoliinone ureaderivatives (7a-j and 9a-e) respectivelyand these were prepared by 
the coupling of 3-chloropropyl isocyanide,2-chloroethyl isocyanide with amino-
quinazolinones (14a-j), as shown in Scheme 4. Aminoquinazolinones were obtained by 
the reduction with the correspondingnitro-quinazolinones(13a-e) and the crucial 
intermediates such as compounds of these nitro-quinazolinones were obtained by 





Scheme  4& 5: Reagents and conditions: (a) AC2O, reflux,  1h, 95%; (b) ACOH, reflux, 3h, 




 A series of quinazolinone urea derivatives (6a-j, 7a-j, 8a-eand 9a-e) were 
designedsynthesized and evaluated for their cytotoxicity against different human cancer 
cell lines. Compounds 7a, 7cand 9a exhibited significant antiproliferative activity 
against all most of the cell lines, with IC50 value of < 1 µM.Most of the compounds 
that exhibit antitumor activity against various cancer cell lines as well as tubulin 
polymerization inhibition. 
(Manuscript prepared for Chem. Med.Chem) 
 
 
Synthesis and Biological Evaluation of Quinazolinone-Arylpropenones Derivatives 
as Potential Anticancer Agents 
 Several quinazolinone derivatives were synthesized recently with an aim of 
finding related compounds having therapeutic efficacy with less side effects. In the 
process HMJ-38 is reported as the most potent 2-phenyl-4-quinozolinone derivative in 
inhibiting the tubulin polymerization (Fig. 6) and showed significant cytotoxicity 






interest in the chemistry of quinazolinones because of their wide range of biological 
significance. 
 2-Styryl quinazolinone (XIII) derivatives form an important component of 
pharmacologically active compounds because they are associated with inhibitory 
effects on tubulin polymerization, as shown in Figure. Poly(ADP-ribose) polymerase 
(PARP) is anabundant nuclear enzyme which is involved in a number of cellular 
processes like DNA repair and programmed cell death. Indole derivatives(2) and (3)  is 
known to inhibit this DNA repair enzyme poly(ADP-ribose) polymerase (PARP) 
Therapeutic agents containing the quinazolinone core structure are in the clinic and as 
well undergoing clinical trials for the treatment of cancer. And Reddy group in (2012) 
reported a series of(Z)-arylaminopropenones (XVI) and (XVII) molecules, which 
induce apoptotic death of a wide variety of human tumor celllines at nanomolar 
concentrations by promoting Anti cancer activity.  
 
Figure 6: Chemical structures ofbiologically active quinazolinone, indole and 
arylpropenone derivatives  
Chemistry  
 Aryl (phenylamino) propenonequinazolinone (6a-jand 7a-e) derivatives were 
prepared by thephenylquinazolinonederivatives(8a-e), with the arylpropenone 
derivatives in ethanol solvent. The reaction mixture was stirred at a temperature of 25-
35 °C for 4 h and these amino-quinazolinones (14a-e), as shown in Scheme 6 were 




crucial intermediates such as compounds of these nitro-quinazolinones were obtained 
by reaction with substituted anilines (6a-j) with 5-nitro anthranilicacid(10). 
 
 
Scheme 5: Reagents & conditions: (i) (CH3CO)2O, 150 
oC, 30 min.; (ii) Substituted anilines, 
AcOH, reflux, 4 h; (iii) Pd-C, H2, EtOH, rt, 3 h.(iv)Ethynylmagnesium bromide, THF, 0 
oC, 2 h 
(v) IBX, DMSO, rt, 4 h, (vi)EtOH, rt, 3 h. 
Summary 
 A series of (Z)-1-Aryl (phenylamino) propenonequinazolinone (6a-jand7a-e) 
were designed, synthesized and evaluated for their cytotoxicity against different human 
cancer cell lines. Compounds 6a and 7aexhibited significant antiproliferative activity 
against all most of the cell lines, with IC50 value of 1.23-3.73µM. Most of the 
compounds that exhibit antitumor activity against various cancer cell lines as well as 
tubulin polymerization inhibition. 










Discovery of PyrrolospirooxindoleDerivatives as DovelCyclinDependent kinase 4 
(CDK4) Inhibitors by Catalyst-free, Green Approach  
 Spirocyclic compounds are notable for their molecular architecture as well as 
the prominent biological activities.Especially, spirocyclicoxindoles are attractive 
synthetic targets because of their widespread occurrence in various natural products and 
biologically active molecules. The structural rigidity imparted by the spiro-carbon 
causes conformational restrictions and this may influence the binding of such 
compounds to the biological targets favourably. A selected assortment of natural 
products incorporating the spirooxindole unit is depicted in Figure. Spirotryprostatin A 
and B (XXIaand XXIb) are two natural alkaloids isolated from the fermentation broth 
of Aspergillus fumigates, that have been identified as promising inhibitors of 
microtubule assembly(Fig. 7).  Spirooxindole systems also constitute the core scaffold 
of many synthetic pharmaceuticals with a wide range of biological applications such as 







Figure7: Chemical structures ofbiologically active spirooxindole derivatives and 
CDK4 inhibitors 
 In the course of our interest to develop nitrogen heterocyclic compounds as 
anticancer agents, prompted us to investigate the biological activity of spirooxindole 
scaffold in detail. This called for a convenient and practical method for the synthesis of 
the spirooxindole unit. Literature survey reveals that 1,3-dipolar cycloaddition reactions 
have been used extensively to prepare spirooxindole derivatives. The preparation of 
such compounds via the reaction of isatin and N-(2-aminophenyl)pyrrole at room 
temperature  in the presence of different catalysts such as molecular iodine, ZnCl2, 
CuCl2, FeCl3, p-TSA, Sulfamic acid and HCl are also reported. In many cases the 
desired products were obtained in very low to moderate yields. Our efforts led to the 
development of a catalyst-free synthesis of pyrrole fused spirooxindoles in ethanol 
(Scheme 6).  
 
Scheme 6:Green synthesis of cytotoxic spirooxindole derivatives 
 In conclusion, a simple, mild, efficient and environmentally benign method for 
the synthesis of 5'H-spiro[indoline-3,4'-pyrrolo(1,2-a)quinoxalin]-2-ones has been 
developed without using a catalysts in ethanol. The advantages of this method include 
its simplicity of operation, cleaner reactions, absence of side products and higher 
yields. Further, the purification of the product is simple, involving a simple filtration 
and washing. The synthesized compounds are tested for their cytotoxocity and they 
exhibit IC50 values in the range 31.44 - 1.16 µM. Compound 3n with piperonyl 
substitution on 5-chloroisatin nitrogen displayed the highest cyctotoxicity in the series. 
Its IC50 values are comparable to that of the positive control, doxorubicin. Further 




V-FITC assay and Western blot analysis indicated that 3n induces cell death by 
apoptosis.  
Eur. J. Med. Chem. 2016, 108, 476-485. 
 
Acid catalyzed green synthesis of novel pyrazolopyrimidineDerivatives and their 
biological evaluation. 
 The pyrazolo-pyrimidine scaffold is a highly adaptable drug-like template, 
which is extensively used in the design of cellular apoptosis and cancer therapies. 
These compounds are capable to exert significant anticancer effects by the inhibition of 
different types of proteins, enzymes, and receptors which play crucial roles in cell 
division.Consequently, the synthesis and development of pyrazolo-fused derivatives 
have been emerged as an important heterocyclic system due to their broad area of 
biological activitiesas well as synthetic applications in medicinal 
chemistry.Particularly, pyrazolo[3,4-d]pyrimidine has been a fruitful source of 
inspiration for medicinal chemists for many years and attracted their attention due to 
their numerous activities.These derivatives exhibit a wide range of biological activities 
such as antitumor, anxiolytic and antimicrobial.  
 In addition, pyrazolo[1,5-a]pyrimidine compounds are widely used as inhibitors 
of  cyclin-dependent kinases (CDKs), that are involved in mediating the transmission of 
mitogenic signals and numerous other cellular eventsincluding cell proliferation, 
differentiation, migration, metabolism and immune response. It is also observed that 
many of these derivatives may block proliferation of various cancer cell lines. Some of 
the selective CDK inhibitors (XXIII to XXV) have been described in the literature that 






Figure 8: Chemical structures ofbiologically active pyrazolo[1,5-a]pyrimidine 
derivatives and CDK4 inhibitors 
 
Chemistry 
 Our studies began with exploring various non-catalytic routes for the 
cyclocondensation reaction between 1H-pyrazol-5-amine and keto-alkyne 
derivatives(Scheme 1).Some of the representative reaction conditions that were 
investigated,it was observed that this reaction did not proceed at room temperature 
when run without any catalyst in water, acetonitrile, methanol or ethanol. Interestingly, 
the product 3a was obtained in 73% by adding the hydrochloric acid reaction at room 
temperature for 4 h. Subsequently it was revealed that the cyclocondensation proceeds 
efficiently in all the solvents tested under acidic conditions. Though PTSA in water and 
ethanol afforded high yields of products,as well, by the completion of reaction just 
filtration of the crude mixture obtained a pure product. Considering the operational 
simplicity water was preferred over other as the solvent. 
 Scheme 7: Green synthesis of pyrazolo-pyrimidinederivatives  
 In conclusion, a simple, mild, efficient and environmentally benign method for 




catalysts in water. The advantages of this method include its simplicity of operation, 
cleaner reactions, absence of side products and higher yields. Further, the purification 
of the product is simple, involving a simple filtration and washing.  
(Manuscript prepared for RSC. Adv.) 
 
